Zenvia Inc. (ZENV) Stock Forecast
Data as of May 2, 2026Technology · Current price $0.47 (-16.30%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jun 3, 2024 | Leonardo Olmos | UBS | $3.30 | +603.8% |
| Jul 4, 2022 | Diego Aragao | Goldman Sachs | $3.40 | +625.1% |
Top Analysts Covering ZENV
ZENV vs Sector & Market
| Metric | ZENV | Technology Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.34 | 2.41 |
| Analyst Count | — | 13 | 18 |
| Target Upside | +614.4% | +4071.6% | +14.9% |
| P/E Ratio | -0.70 | 27.94 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.02B | $1.02B | $1.02B | 1 |
| 2027-12-31 | $1.05B | $1.05B | $1.05B | 1 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-0.22 | $-0.22 | $-0.22 | 1 |
| 2027-12-31 | $0.54 | $0.54 | $0.54 | 1 |
Frequently Asked Questions
What is the analyst consensus for ZENV?
The consensus among 0 analysts covering Zenvia Inc. (ZENV) is — with an average price target of $3.35.
What is the highest price target for ZENV?
The highest price target for ZENV is $3.40, set by Diego Aragao at Goldman Sachs on 2022-07-04.
What is the lowest price target for ZENV?
The lowest price target for ZENV is $3.30, set by Leonardo Olmos at UBS on 2024-06-03.
How many analysts cover ZENV?
0 analysts have issued ratings for Zenvia Inc. in the past 12 months.
Is ZENV a buy or sell right now?
Based on 0 analyst ratings, ZENV has a consensus rating of — with a +614.4% upside to the consensus target of $3.35.
What are the earnings estimates for ZENV?
Analysts estimate ZENV will report EPS of $-0.22 for the period ending 2026-12-31, with revenue estimated at $1.02B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.